REFERENCES
- Aamodt RL, Coon JS, Deitch A, et al. Flow cytometric evaluation of bladder cancer: recommendations of the NCI flow cytometry network for bladder cancer. World J Urol 1992; 10: 63–67.
- Al-Abadi H, Nagel R. Deoxyribonucleic acid content and survival rates of patients with transitional cell carcinoma of the bladder. J Urol 1994; 151: 37–42.
- Collste LG, Devonec M, Darzynkiewicz Z, et al. Bladder cancer diagnosis by flow cytometry. Correlation between cell samples from biopsy and bladder irrigation fluid. Cancer 1980; 45: 2389.
- Coon JS, Deitch AD, de Vere White RW, et al. Check samples for laboratory self-assessment in DNA flow cytometry. The National Cancer Institute's flow cytometry network experience. Cancer 1988; 63: 1592–1599.
- Fosså SD, Berner AA, Jacobsen A-B, et al. Clinical significance of DNA ploidy and S-phase fraction and their relation to p53 protein, c-erbB-2 protein and HCG in operable muscle-invasive bladder cancer. Br J Cancer 1993; 68: 572–578.
- Giella JG, Ring K, Olsson CA, Karp FS, Benson MC. The predictive value of flow cytometry and urinary cytology in the followup of patients with transitional cell carcinoma of the bladder. J Urol 1992; 148: 293–296.
- Hemstreet GP, Rollins S, Jones P, et al. Identification of a high risk subgroup of grade 1 transitional cell carcinoma using image analysis based deoxyribonucleic acid ploidy analysis of tumor tissue. J Urol 1991; 146: 1525–1529.
- Hermanek P, Sobin LH. TNM classification of malignant tumors. New York: Springer Verlag, 1987.
- Hug EB, Donnelly SM, Shipley WU, et al. Deoxyribonucleic acid flow cytometry in invasive bladder carcinoma: A possible predictor for successful bladder preservation following transurethral surgery and chemotherapy-radiotherapy. J Urol 1992; 148: 47–51.
- Jacobsen AB, Pettersen EO, Åmellen Ö, Berner A, Ous S, Fosså SD. The prognostic significance of deoxyribonucleic acid flow cytometry in muscle invasive bladder carcinoma treated with preoperative irradiation and cystectomy. J Urol 1992; 147: 34–37.
- Lipponen PK, Nordling S, Eskelinen MJ, Jauhiainen K, Terho R, Harju E. Flow cytometry in comparison with mitotic index in predicting disease outcome in transitional cell bladder cancer. Int J Cancer 1993; 53; 42–47.
- Melamed MR. Flow cytometry of the urinary bladder. Urol Clin North Am 1984; 11: 599–608.
- Mostofi FK, Sobin LH, Torloni H. International Histological Classification of Tumours. Geneva: World Health Organization, 1973.
- Norming U, Tribukait B, Gustafson H, Nyman CR, Wang N, Wijkström H. Deoxyribonucleic acid profile and tumor progression in primary carcinoma in situ of the bladder - A study of 63 patients with grade 3 lesions. J Urol 1992; 147: 11–15.
- Richards B, Parmar MKB, Anderson CK. Superficial bladder cancer subgroup: Interpretation of biopsies of ‘normal’ urothelium in patients with superficial bladder cancer. Br J Urol 1991; 67: 364–375.
- Slack NH, Prout GR. The heterogeneity of invasive bladder carcinoma and different responses to treatment. J Urol 1980; 123: 644–652.
- Smith G, Elton RA, Chisholm GD, Newsam JE, Hargreave TB. Superficial bladder cancer. Intravesical chemotherapy and tumour progression to muscle invasion or metastasis. Br J Urol 1986; 58: 659–663.
- Tachibana M, Deguchi N, Baba S, Jitsukawa S, Hata M, Tazaki H. Multivariate analysis of flow cytometric deoxyribonucleic acid parameters and histological features for prognosis of bladder cancer patients. J Urol 1991; 146: 1530–1534.
- Vindelöv LL, Christensen IJ, Nissen NI. A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry 1983; 3: 323–327.
- Wijkström H, Gustafson H, Tribukait B. Deoxyribonucleic acid analysis in the evaluation of transitional cell carcinoma before cystectomy. J Urol 1984; 132: 894–898.
- Wijkström H, Tribukait B. Deoxyribonucleic acid flow cytometry in predicting response to radical radiotherapy of bladder cancer. J Urol 1990; 144: 646–651.
- Wolf H, Höjgaard K. Prognostic factors in local surgical treatment of invasive bladder cancer with special reference to the presence of urothelial dysplasia. Cancer 1983; 51: 1710–1715.